Maternal-Fetal Medicine — MCQs

Q: What is the most common causative organism of acute pyelonephritis in pregnancy?

E. coli. **Explanation:** **1. Why E. coli is correct:** *Escherichia coli* is the most common causative organism for acute pyelonephritis in pregnancy, accounting for approximately **70–80% of cases**. The primary mechanism is the ascending route of infection. During pregnancy, physiological changes such as progesterone-induced smooth muscle relaxation (leading to ureteral dilatation) and mechanical compression of the ureters by the gravid uterus cause **urinary stasis**. This environment, combined with pregnancy-induced glycosuria and aminoaciduria, facilitates the upward migration of fecal flora (E. coli) from the perineum to the upper urinary tract. **2. Why the other options are incorrect:** * **B & C (Klebsiella and Enterobacter):** While these are Gram-negative bacilli that can cause UTIs, they are significantly less common than E. coli, typically accounting for only 3–5% of cases each. They are more frequently seen in recurrent infections or hospital-acquired settings. * **D (Staphylococcus group):** Gram-positive organisms like *Staphylococcus saprophyticus* or Group B Streptococcus (GBS) are occasional causes of UTI in pregnancy, but they represent a small minority of pyelonephritis cases compared to the overwhelming prevalence of E. coli. **3. NEET-PG High-Yield Pearls:** * **Most common medical complication** requiring hospitalization during pregnancy: Acute Pyelonephritis. * **Most common site:** Right side (due to dextrorotation of the uterus and protection of the left ureter by the sigmoid colon). * **Screening:** All pregnant women should be screened for **Asymptomatic Bacteriuria (ASB)** at the first prenatal visit (12–16 weeks). If untreated, 25–40% of ASB cases progress to acute pyelonephritis. * **Complications:** Can lead to preterm labor, maternal sepsis, and ARDS.

Q: Which is the most common complication in monoamniotic twins?

Intertwining. **Explanation:** Monoamniotic-monochorionic (MoMo) twins occur when the zygote divides late, between **8 to 12 days** post-fertilization. Because both fetuses reside in a single amniotic sac without a dividing membrane, they are at unique risk for specific complications. **1. Why "Intertwining" is correct:** **Cord entanglement (Intertwining)** is the most common and characteristic complication of monoamniotic twins, occurring in nearly **100% of cases** in utero. As the fetuses move within the single sac, their umbilical cords inevitably twist around each other. While not always fatal, it can lead to sudden cord occlusion and fetal demise, which is why these pregnancies are managed with intensive monitoring and elective Cesarean delivery (usually at 32–34 weeks). **2. Analysis of Incorrect Options:** * **Discordance (A):** While growth discordance occurs in twins, it is more classically associated with Twin-to-Twin Transfusion Syndrome (TTTS) in diamniotic-monochorionic twins. * **Cord entanglement (B):** In many textbooks and exams, "Intertwining" and "Cord entanglement" are used interchangeably; however, "Intertwining" is the preferred clinical term for the specific phenomenon of the two cords wrapping around one another. * **Conjoined twins (C):** This is a rare complication occurring only if the zygote divides even later (**after 13 days**). While specific to monoamniotic gestations, it is far less common than cord intertwining. **High-Yield Clinical Pearls for NEET-PG:** * **Timing of Division:** 0–72 hours (Di-Di), 4–8 days (Mo-Di), 8–12 days (Mo-Mo), >13 days (Conjoined). * **Management:** MoMo twins require inpatient monitoring from 24–28 weeks and delivery via **LSCS by 32–34 weeks** to prevent late-term fetal death from cord accidents. * **The "T-sign" vs. "Lambda sign":** MoMo twins show **neither**; there is no dividing membrane at all.

Q: Placental enlargement is seen in which of the following infections?

Plasmodium. **Explanation:** **Correct Answer: D. Plasmodium** **Why Plasmodium is correct:** Placental enlargement (placentomegaly) in malaria, particularly *Plasmodium falciparum*, is a hallmark of **Placental Malaria**. The underlying mechanism involves the sequestration of parasitized red blood cells in the intervillous spaces. This triggers a robust maternal inflammatory response, leading to massive infiltration of monocytes and macrophages (intervillositis), fibrin deposition, and basement membrane thickening. These pathological changes significantly increase placental weight and thickness, often correlating with adverse outcomes like intrauterine growth restriction (IUGR) and low birth weight. **Analysis of Incorrect Options:** * **A, B, and C (Toxoplasma, CMV, Parvovirus):** While these infections are part of the TORCH spectrum and can occasionally cause placental edema or "hydrops-like" changes, they are primarily associated with **placental calcifications** (especially CMV and Toxoplasma) or specific fetal effects (e.g., Parvovirus causing fetal anemia and hydrops). In the context of standard PG-level examinations, *Plasmodium* is the classic infectious cause cited for significant placental hypertrophy and weight increase. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of Placentomegaly:** A placental thickness >4 cm in the second/third trimester or a weight >600g at term. * **Other Causes of Placentomegaly:** * **Maternal:** Diabetes Mellitus (most common non-infectious cause), Severe Anemia. * **Fetal:** Rh-Isoimmunization (Hydrops Fetalis), Twin-to-Twin Transfusion Syndrome (recipient), Chromosomal anomalies (Triploidy). * **Tumors:** Chorioangioma. * **Malaria Fact:** Placental malaria is more common and severe in **primigravidae** due to the lack of specific immunity against VAR2CSA-expressing parasites that bind to chondroitin sulfate A in the placenta.

Q: Which of the following is associated with an increased incidence of heterotopic pregnancy?

Assisted reproductive technologies. **Explanation:** **Heterotopic pregnancy** is a rare clinical condition defined by the simultaneous presence of an intrauterine pregnancy and an ectopic pregnancy. **1. Why Assisted Reproductive Technologies (ART) is correct:** In the general population, the incidence of heterotopic pregnancy is approximately 1 in 30,000. However, with the rise of **Assisted Reproductive Technologies (ART)**, such as IVF and embryo transfer, the incidence increases significantly to about **1 in 100 to 1 in 500**. The primary mechanism is the transfer of multiple embryos into the uterus and the use of high-pressure catheters, which can inadvertently propel an embryo into the fallopian tube while another implants in the endometrium. **2. Why other options are incorrect:** * **Obesity:** While obesity is a risk factor for various pregnancy complications (like gestational diabetes), it is not a specific risk factor for heterotopic or ectopic pregnancy. * **Multiparity:** Higher parity does not increase the risk of heterotopic pregnancy. In fact, nulliparity is more often associated with ART use. * **Prior Cesarean Delivery:** This increases the risk of *placenta accreta* or *cesarean scar ectopic pregnancy*, but it is not the primary driver for a dual-site heterotopic pregnancy. **3. NEET-PG High-Yield Pearls:** * **Most common site:** The most common site for the ectopic component in a heterotopic pregnancy is the **Fallopian tube** (specifically the ampulla). * **Clinical Suspicion:** Always suspect heterotopic pregnancy in an ART patient who presents with an intrauterine pregnancy on ultrasound but has persistent abdominal pain or free fluid in the pouch of Douglas. * **Management:** The goal is to surgically remove the ectopic pregnancy (usually via laparoscopy) while preserving the viable intrauterine pregnancy. Methotrexate is **contraindicated** as it would terminate the intrauterine fetus.

Q: What is the impact on the fetus in case of use of Indomethacin in utero in the third trimester?

Early closure of ductus arteriosus. **Explanation:** **Mechanism of Action:** Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) that acts as a non-selective **cyclooxygenase (COX) inhibitor**. In the fetus, the patency of the ductus arteriosus is actively maintained by high levels of circulating **Prostaglandin E2 (PGE2)**. By inhibiting COX enzymes, Indomethacin decreases prostaglandin synthesis, leading to the **premature (early) closure of the ductus arteriosus** in utero. This can result in fetal pulmonary hypertension and right-sided heart failure. **Analysis of Options:** * **Option B (Correct):** As explained, PGE2 inhibition leads to constriction and premature closure of the ductus. This risk increases significantly when used after **32 weeks** of gestation. * **Option A:** Patent Ductus Arteriosus (PDA) is the failure of the ductus to close *after* birth. Interestingly, Indomethacin is used postnatally to *treat* PDA, but its prenatal use causes the opposite (premature closure). * **Options C & D:** Ventricular and Atrial Septal Defects are structural congenital heart diseases related to embryological development in the first trimester. Indomethacin does not cause these malformations when used in the third trimester. **High-Yield Clinical Pearls for NEET-PG:** * **Tocolysis:** Indomethacin is used as a second-line tocolytic for preterm labor, but only before 32 weeks. * **Oligohydramnios:** Another major side effect of Indomethacin is reduced fetal urine output, leading to oligohydramnios (often used therapeutically in polyhydramnios). * **Monitoring:** If used for >48 hours, serial fetal echocardiography is mandatory to monitor the ductal flow and amniotic fluid index. * **Contraindication:** It is generally avoided after 32 weeks due to the high sensitivity of the fetal ductus to prostaglandins at this stage.

Q: Oligohydramnios is seen in which of the following conditions?

Renal agenesis. **Explanation:** **Correct Answer: A. Renal agenesis** The volume of amniotic fluid is a balance between production and removal. From the second trimester onwards, **fetal urine** is the primary source of amniotic fluid. In **Renal agenesis** (Potter sequence), the absence of kidneys leads to a lack of urine production (anuria), resulting in **Oligohydramnios** (Amniotic Fluid Index < 5 cm or Single Deepest Pocket < 2 cm). **Why the other options are incorrect:** * **B. Oesophageal atresia:** Fetal swallowing is the major pathway for amniotic fluid removal. In esophageal atresia, the fetus cannot swallow the fluid, leading to its accumulation and **Polyhydramnios**. * **C. Exomphalos (Omphalocele):** This is a ventral wall defect. It is generally associated with **Polyhydramnios** due to the exudation of fluid from the exposed bowel or associated chromosomal/structural anomalies that interfere with swallowing. * **D. Neural tube defect (NTD):** Open NTDs (like Anencephaly) cause **Polyhydramnios** via two mechanisms: the absence of the swallowing reflex and the transudation of cerebrospinal fluid across the exposed neural membranes. **High-Yield Clinical Pearls for NEET-PG:** * **Potter Sequence:** Renal agenesis → Oligohydramnios → Pulmonary hypoplasia, limb deformities, and flattened facies. * **Amniotic Fluid Index (AFI):** Normal range is 5–25 cm. * **Common causes of Oligohydramnios (DRIPPC):** **D**eath (fetal), **R**enal anomalies, **I**UGR, **P**rom (Premature Rupture of Membranes), **P**ost-term pregnancy, **C**hromosomal anomalies. * **Indomethacin:** A common drug-induced cause of oligohydramnios (due to reduced fetal renal blood flow).

Q: An ectopic pregnancy is shed as?

Decidua vera. In an ectopic pregnancy, the hormonal changes (rising progesterone) stimulate the transformation of the endometrium into **decidua**, despite the embryo being implanted outside the uterine cavity. ### Why Decidua Vera is Correct The endometrium undergoes a "decidual reaction" to prepare for implantation. In a normal intrauterine pregnancy, the decidua is divided into three layers: 1. **Decidua Basalis:** Where the blastocyst implants. 2. **Decidua Capsularis:** Covers the blastocyst. 3. **Decidua Vera (Parietalis):** Lines the remainder of the uterine cavity. In an **ectopic pregnancy**, there is no blastocyst inside the uterus to create the basalis or capsularis layers. Therefore, the entire uterine lining transforms uniformly into **Decidua Vera**. When the ectopic pregnancy fails and hormone levels fall, this lining sloughs off and is shed, often as a single intact piece known as a **decidual cast**. ### Why Other Options are Incorrect * **Decidua Basalis & Capsularis:** These layers only form in response to the physical presence and implantation of the embryo within the uterus. Since the embryo is extrauterine, these specific layers do not exist. * **Decidua Rubra:** This is not a standard anatomical term for the decidual layers; it is likely a distractor derived from "Lochia Rubra" (the bloody discharge seen postpartum). ### NEET-PG Clinical Pearls * **Arias-Stella Reaction:** This is the characteristic histological change seen in the endometrium during ectopic pregnancy, featuring hypersecretory glands and nuclear hypertrophy. * **Decidual Cast:** If a patient presents with abdominal pain and passes a fleshy mass per vaginum, it is often a decidual cast. This must be differentiated from a miscarriage (which would contain chorionic villi). * **Key Distinction:** The absence of chorionic villi on histopathology of the shed tissue is a strong indicator of ectopic pregnancy.

Maternal-Fetal Medicine Indian Medical PG Practice Questions and MCQs

Question 1: What is the most common causative organism of acute pyelonephritis in pregnancy?

A. E. coli (Correct Answer)
B. Klebsiella pneumoniae
C. Enterobacter
D. Staphylococcus group

Explanation: **Explanation:** **1. Why E. coli is correct:** *Escherichia coli* is the most common causative organism for acute pyelonephritis in pregnancy, accounting for approximately **70–80% of cases**. The primary mechanism is the ascending route of infection. During pregnancy, physiological changes such as progesterone-induced smooth muscle relaxation (leading to ureteral dilatation) and mechanical compression of the ureters by the gravid uterus cause **urinary stasis**. This environment, combined with pregnancy-induced glycosuria and aminoaciduria, facilitates the upward migration of fecal flora (E. coli) from the perineum to the upper urinary tract. **2. Why the other options are incorrect:** * **B & C (Klebsiella and Enterobacter):** While these are Gram-negative bacilli that can cause UTIs, they are significantly less common than E. coli, typically accounting for only 3–5% of cases each. They are more frequently seen in recurrent infections or hospital-acquired settings. * **D (Staphylococcus group):** Gram-positive organisms like *Staphylococcus saprophyticus* or Group B Streptococcus (GBS) are occasional causes of UTI in pregnancy, but they represent a small minority of pyelonephritis cases compared to the overwhelming prevalence of E. coli. **3. NEET-PG High-Yield Pearls:** * **Most common medical complication** requiring hospitalization during pregnancy: Acute Pyelonephritis. * **Most common site:** Right side (due to dextrorotation of the uterus and protection of the left ureter by the sigmoid colon). * **Screening:** All pregnant women should be screened for **Asymptomatic Bacteriuria (ASB)** at the first prenatal visit (12–16 weeks). If untreated, 25–40% of ASB cases progress to acute pyelonephritis. * **Complications:** Can lead to preterm labor, maternal sepsis, and ARDS.

Question 2: Which is the most common complication in monoamniotic twins?

A. Discordance
B. Cord entanglement
C. Conjoined twins
D. Intertwining (Correct Answer)

Explanation: **Explanation:** Monoamniotic-monochorionic (MoMo) twins occur when the zygote divides late, between **8 to 12 days** post-fertilization. Because both fetuses reside in a single amniotic sac without a dividing membrane, they are at unique risk for specific complications. **1. Why "Intertwining" is correct:** **Cord entanglement (Intertwining)** is the most common and characteristic complication of monoamniotic twins, occurring in nearly **100% of cases** in utero. As the fetuses move within the single sac, their umbilical cords inevitably twist around each other. While not always fatal, it can lead to sudden cord occlusion and fetal demise, which is why these pregnancies are managed with intensive monitoring and elective Cesarean delivery (usually at 32–34 weeks). **2. Analysis of Incorrect Options:** * **Discordance (A):** While growth discordance occurs in twins, it is more classically associated with Twin-to-Twin Transfusion Syndrome (TTTS) in diamniotic-monochorionic twins. * **Cord entanglement (B):** In many textbooks and exams, "Intertwining" and "Cord entanglement" are used interchangeably; however, "Intertwining" is the preferred clinical term for the specific phenomenon of the two cords wrapping around one another. * **Conjoined twins (C):** This is a rare complication occurring only if the zygote divides even later (**after 13 days**). While specific to monoamniotic gestations, it is far less common than cord intertwining. **High-Yield Clinical Pearls for NEET-PG:** * **Timing of Division:** 0–72 hours (Di-Di), 4–8 days (Mo-Di), 8–12 days (Mo-Mo), >13 days (Conjoined). * **Management:** MoMo twins require inpatient monitoring from 24–28 weeks and delivery via **LSCS by 32–34 weeks** to prevent late-term fetal death from cord accidents. * **The "T-sign" vs. "Lambda sign":** MoMo twins show **neither**; there is no dividing membrane at all.

Question 3: Placental enlargement is seen in which of the following infections?

A. Toxoplasma
B. Cytomegalovirus (CMV)
C. Parvovirus
D. Plasmodium (Correct Answer)

Explanation: **Explanation:** **Correct Answer: D. Plasmodium** **Why Plasmodium is correct:** Placental enlargement (placentomegaly) in malaria, particularly *Plasmodium falciparum*, is a hallmark of **Placental Malaria**. The underlying mechanism involves the sequestration of parasitized red blood cells in the intervillous spaces. This triggers a robust maternal inflammatory response, leading to massive infiltration of monocytes and macrophages (intervillositis), fibrin deposition, and basement membrane thickening. These pathological changes significantly increase placental weight and thickness, often correlating with adverse outcomes like intrauterine growth restriction (IUGR) and low birth weight. **Analysis of Incorrect Options:** * **A, B, and C (Toxoplasma, CMV, Parvovirus):** While these infections are part of the TORCH spectrum and can occasionally cause placental edema or "hydrops-like" changes, they are primarily associated with **placental calcifications** (especially CMV and Toxoplasma) or specific fetal effects (e.g., Parvovirus causing fetal anemia and hydrops). In the context of standard PG-level examinations, *Plasmodium* is the classic infectious cause cited for significant placental hypertrophy and weight increase. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of Placentomegaly:** A placental thickness >4 cm in the second/third trimester or a weight >600g at term. * **Other Causes of Placentomegaly:** * **Maternal:** Diabetes Mellitus (most common non-infectious cause), Severe Anemia. * **Fetal:** Rh-Isoimmunization (Hydrops Fetalis), Twin-to-Twin Transfusion Syndrome (recipient), Chromosomal anomalies (Triploidy). * **Tumors:** Chorioangioma. * **Malaria Fact:** Placental malaria is more common and severe in **primigravidae** due to the lack of specific immunity against VAR2CSA-expressing parasites that bind to chondroitin sulfate A in the placenta.

Question 4: Hemolytic disease of the newborn is least common with which blood group female?

A. A
B. B
C. O (Correct Answer)
D. AB

Explanation: **Explanation:** The correct answer is **O**. This question refers to the risk of **Rh isoimmunization** (Rh incompatibility), which is the most severe form of hemolytic disease of the newborn (HDN). **Why Option C is correct:** In Rh isoimmunization, a Rh-negative mother carries a Rh-positive fetus. If the mother and fetus are also **ABO incompatible** (e.g., Mother is Type O and Fetus is Type A or B), the risk of Rh sensitization is significantly **reduced**. This is because any fetal red blood cells (RBCs) entering the maternal circulation are rapidly destroyed by the mother’s naturally occurring anti-A or anti-B antibodies before her immune system can recognize the Rh (D) antigen and produce anti-D antibodies. Since Type O individuals possess both anti-A and anti-B antibodies, they have the highest likelihood of ABO incompatibility with a non-O fetus, thereby providing a "protective effect" against Rh isoimmunization. **Why other options are incorrect:** * **Options A and B:** Mothers with blood group A or B only possess one type of isoagglutinin (anti-B or anti-A, respectively). They are less likely to have ABO incompatibility with the fetus compared to Type O mothers, leading to a higher risk of Rh sensitization. * **Option D (AB):** A mother with blood group AB has no anti-A or anti-B antibodies. Therefore, there is no ABO-mediated destruction of fetal cells, making her the most susceptible to Rh isoimmunization if she is Rh-negative. **High-Yield Clinical Pearls for NEET-PG:** 1. **ABO Incompatibility vs. Rh Incompatibility:** While ABO incompatibility is more common and can occur in the *first* pregnancy, it is clinically milder. Rh incompatibility is more severe and typically affects *subsequent* pregnancies. 2. **Protective Effect:** ABO incompatibility reduces the risk of Rh isoimmunization from ~16% to about **1-2%**. 3. **Kleihauer-Betke Test:** Used to quantify the amount of fetal-maternal hemorrhage to determine the dose of Anti-D (RhoGAM). 4. **Indirect Coombs Test (ICT):** Performed on the mother to detect sensitization. A titer of **1:16** is generally considered the critical threshold.

Question 5: Which of the following is associated with an increased incidence of heterotopic pregnancy?

A. Obesity
B. Multiparity
C. Prior cesarean delivery
D. Assisted reproductive technologies (Correct Answer)

Explanation: **Explanation:** **Heterotopic pregnancy** is a rare clinical condition defined by the simultaneous presence of an intrauterine pregnancy and an ectopic pregnancy. **1. Why Assisted Reproductive Technologies (ART) is correct:** In the general population, the incidence of heterotopic pregnancy is approximately 1 in 30,000. However, with the rise of **Assisted Reproductive Technologies (ART)**, such as IVF and embryo transfer, the incidence increases significantly to about **1 in 100 to 1 in 500**. The primary mechanism is the transfer of multiple embryos into the uterus and the use of high-pressure catheters, which can inadvertently propel an embryo into the fallopian tube while another implants in the endometrium. **2. Why other options are incorrect:** * **Obesity:** While obesity is a risk factor for various pregnancy complications (like gestational diabetes), it is not a specific risk factor for heterotopic or ectopic pregnancy. * **Multiparity:** Higher parity does not increase the risk of heterotopic pregnancy. In fact, nulliparity is more often associated with ART use. * **Prior Cesarean Delivery:** This increases the risk of *placenta accreta* or *cesarean scar ectopic pregnancy*, but it is not the primary driver for a dual-site heterotopic pregnancy. **3. NEET-PG High-Yield Pearls:** * **Most common site:** The most common site for the ectopic component in a heterotopic pregnancy is the **Fallopian tube** (specifically the ampulla). * **Clinical Suspicion:** Always suspect heterotopic pregnancy in an ART patient who presents with an intrauterine pregnancy on ultrasound but has persistent abdominal pain or free fluid in the pouch of Douglas. * **Management:** The goal is to surgically remove the ectopic pregnancy (usually via laparoscopy) while preserving the viable intrauterine pregnancy. Methotrexate is **contraindicated** as it would terminate the intrauterine fetus.

Question 6: What is the impact on the fetus in case of use of Indomethacin in utero in the third trimester?

A. Patent ductus arteriosus
B. Early closure of ductus arteriosus (Correct Answer)
C. Ventricular septal defect
D. Atrial septal defect

Explanation: **Explanation:** **Mechanism of Action:** Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) that acts as a non-selective **cyclooxygenase (COX) inhibitor**. In the fetus, the patency of the ductus arteriosus is actively maintained by high levels of circulating **Prostaglandin E2 (PGE2)**. By inhibiting COX enzymes, Indomethacin decreases prostaglandin synthesis, leading to the **premature (early) closure of the ductus arteriosus** in utero. This can result in fetal pulmonary hypertension and right-sided heart failure. **Analysis of Options:** * **Option B (Correct):** As explained, PGE2 inhibition leads to constriction and premature closure of the ductus. This risk increases significantly when used after **32 weeks** of gestation. * **Option A:** Patent Ductus Arteriosus (PDA) is the failure of the ductus to close *after* birth. Interestingly, Indomethacin is used postnatally to *treat* PDA, but its prenatal use causes the opposite (premature closure). * **Options C & D:** Ventricular and Atrial Septal Defects are structural congenital heart diseases related to embryological development in the first trimester. Indomethacin does not cause these malformations when used in the third trimester. **High-Yield Clinical Pearls for NEET-PG:** * **Tocolysis:** Indomethacin is used as a second-line tocolytic for preterm labor, but only before 32 weeks. * **Oligohydramnios:** Another major side effect of Indomethacin is reduced fetal urine output, leading to oligohydramnios (often used therapeutically in polyhydramnios). * **Monitoring:** If used for >48 hours, serial fetal echocardiography is mandatory to monitor the ductal flow and amniotic fluid index. * **Contraindication:** It is generally avoided after 32 weeks due to the high sensitivity of the fetal ductus to prostaglandins at this stage.

Question 7: Which of the following are risk factors for preeclampsia?

A. Chronic hypertension, obesity, placental ischemia, multigravidae
B. Chronic hypertension, obesity, placental ischemia, antiphospholipid syndrome (Correct Answer)
C. Placental ischemia, multigravidae, antiphospholipid syndrome
D. Chronic hypertension, multigravidae, antiphospholipid syndrome

Explanation: **Explanation:** Preeclampsia is a multisystem disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. The correct answer is **B** because it correctly identifies four major independent risk factors associated with the development of the disease. 1. **Why Option B is Correct:** * **Chronic Hypertension:** Pre-existing high blood pressure increases the risk of superimposed preeclampsia due to baseline vascular damage. * **Obesity (BMI >30):** Adipose tissue promotes systemic inflammation and oxidative stress, which are key drivers of endothelial dysfunction. * **Placental Ischemia:** This is the central pathophysiology of preeclampsia. Abnormal remodeling of spiral arteries leads to poor placental perfusion, releasing anti-angiogenic factors (like sFlt-1) into the maternal circulation. * **Antiphospholipid Syndrome (APS):** This autoimmune state promotes thrombosis and placental infarction, significantly elevating risk. 2. **Why Other Options are Incorrect:** * **Multigravidae (Options A, C, and D):** This is the primary distractor. **Nulliparity** (being a primigravida) is a major risk factor for preeclampsia. Conversely, being a multigravida (without a history of preeclampsia) is generally considered a **protective factor**. Therefore, any option containing "multigravidae" is incorrect. 3. **NEET-PG High-Yield Pearls:** * **Strongest Risk Factor:** A prior history of preeclampsia (7-fold increase). * **Protective Factor:** Smoking (paradoxically decreases risk, though not recommended due to other fetal risks). * **Prophylaxis:** Low-dose Aspirin (75–150 mg) started before 16 weeks of gestation is recommended for high-risk patients. * **Other Risk Factors:** Nulliparity, advanced maternal age (>35), multifetal gestation, and Diabetes Mellitus.

Question 8: Oligohydramnios is seen in which of the following conditions?

A. Renal agenesis (Correct Answer)
B. Oesophageal atresia
C. Exomphalos
D. Neural tube defect

Explanation: **Explanation:** **Correct Answer: A. Renal agenesis** The volume of amniotic fluid is a balance between production and removal. From the second trimester onwards, **fetal urine** is the primary source of amniotic fluid. In **Renal agenesis** (Potter sequence), the absence of kidneys leads to a lack of urine production (anuria), resulting in **Oligohydramnios** (Amniotic Fluid Index < 5 cm or Single Deepest Pocket < 2 cm). **Why the other options are incorrect:** * **B. Oesophageal atresia:** Fetal swallowing is the major pathway for amniotic fluid removal. In esophageal atresia, the fetus cannot swallow the fluid, leading to its accumulation and **Polyhydramnios**. * **C. Exomphalos (Omphalocele):** This is a ventral wall defect. It is generally associated with **Polyhydramnios** due to the exudation of fluid from the exposed bowel or associated chromosomal/structural anomalies that interfere with swallowing. * **D. Neural tube defect (NTD):** Open NTDs (like Anencephaly) cause **Polyhydramnios** via two mechanisms: the absence of the swallowing reflex and the transudation of cerebrospinal fluid across the exposed neural membranes. **High-Yield Clinical Pearls for NEET-PG:** * **Potter Sequence:** Renal agenesis → Oligohydramnios → Pulmonary hypoplasia, limb deformities, and flattened facies. * **Amniotic Fluid Index (AFI):** Normal range is 5–25 cm. * **Common causes of Oligohydramnios (DRIPPC):** **D**eath (fetal), **R**enal anomalies, **I**UGR, **P**rom (Premature Rupture of Membranes), **P**ost-term pregnancy, **C**hromosomal anomalies. * **Indomethacin:** A common drug-induced cause of oligohydramnios (due to reduced fetal renal blood flow).

Question 9: An ectopic pregnancy is shed as?

A. Decidua vera (Correct Answer)
B. Decidua basalis
C. Decidua capsularis
D. Decidua rubra

Explanation: In an ectopic pregnancy, the hormonal changes (rising progesterone) stimulate the transformation of the endometrium into **decidua**, despite the embryo being implanted outside the uterine cavity. ### Why Decidua Vera is Correct The endometrium undergoes a "decidual reaction" to prepare for implantation. In a normal intrauterine pregnancy, the decidua is divided into three layers: 1. **Decidua Basalis:** Where the blastocyst implants. 2. **Decidua Capsularis:** Covers the blastocyst. 3. **Decidua Vera (Parietalis):** Lines the remainder of the uterine cavity. In an **ectopic pregnancy**, there is no blastocyst inside the uterus to create the basalis or capsularis layers. Therefore, the entire uterine lining transforms uniformly into **Decidua Vera**. When the ectopic pregnancy fails and hormone levels fall, this lining sloughs off and is shed, often as a single intact piece known as a **decidual cast**. ### Why Other Options are Incorrect * **Decidua Basalis & Capsularis:** These layers only form in response to the physical presence and implantation of the embryo within the uterus. Since the embryo is extrauterine, these specific layers do not exist. * **Decidua Rubra:** This is not a standard anatomical term for the decidual layers; it is likely a distractor derived from "Lochia Rubra" (the bloody discharge seen postpartum). ### NEET-PG Clinical Pearls * **Arias-Stella Reaction:** This is the characteristic histological change seen in the endometrium during ectopic pregnancy, featuring hypersecretory glands and nuclear hypertrophy. * **Decidual Cast:** If a patient presents with abdominal pain and passes a fleshy mass per vaginum, it is often a decidual cast. This must be differentiated from a miscarriage (which would contain chorionic villi). * **Key Distinction:** The absence of chorionic villi on histopathology of the shed tissue is a strong indicator of ectopic pregnancy.

Question 10: A patient with systemic lupus erythematosus desires pregnancy. What should her physician advise her regarding pregnancy in lupus patients?

A. There is no increased risk to the fetus.
B. There may be an increase in cardiovascular malformations.
C. There may be an increase in nervous system malformations.
D. There may be an increase in spontaneous abortions and prematurity. (Correct Answer)

Explanation: **Explanation:** Systemic Lupus Erythematosus (SLE) is an autoimmune multisystem disorder that significantly impacts pregnancy outcomes. The correct answer is **D** because SLE is associated with a high incidence of obstetric complications. The underlying pathophysiology involves placental vasculopathy, decidual vasculitis, and the presence of antiphospholipid antibodies (APA), which lead to placental insufficiency. This results in a 2–3 fold increase in **spontaneous abortions**, **preterm labor** (often iatrogenic due to preeclampsia or fetal distress), and **Intrauterine Growth Restriction (IUGR)**. **Analysis of Incorrect Options:** * **Option A:** Incorrect. SLE is a high-risk pregnancy. There is a significant risk of fetal loss, stillbirth, and neonatal lupus. * **Options B & C:** Incorrect. SLE is generally **not teratogenic**. Unlike drugs like thalidomide or poorly controlled diabetes, SLE does not increase the risk of structural cardiovascular or nervous system malformations. However, it is crucial to distinguish *malformations* from *functional defects*: SLE is associated with **congenital heart block** (permanent) due to anti-Ro/SSA and anti-La/SSB antibodies, but this is a conduction defect, not a structural malformation. **High-Yield Clinical Pearls for NEET-PG:** * **Pre-conception Counseling:** Pregnancy should ideally be planned after at least **6 months of clinical remission**. * **Neonatal Lupus:** Characterized by congenital heart block (irreversible) and skin rashes (reversible). It is mediated by the transplacental passage of **anti-Ro (SSA)** and **anti-La (SSB)** antibodies. * **Drug of Choice:** **Hydroxychloroquine** is safe and should be continued throughout pregnancy to prevent flares. * **Lupus vs. Preeclampsia:** Differentiating a lupus flare from preeclampsia is a common exam challenge; low complement levels (C3, C4) and active urinary sediment suggest a lupus flare.

Practice by Chapter

Fetal Assessment Techniques

Practice Questions

Hypertensive Disorders in Pregnancy

Practice Questions

Intrauterine Growth Restriction

Practice Questions

Multiple Gestation

Practice Questions

Rh Isoimmunization and Other Blood Group Incompatibilities

Practice Questions

Intrauterine Fetal Therapy

Practice Questions

Prenatal Diagnosis and Genetic Counseling

Practice Questions

Placental Abnormalities

Practice Questions

Preterm Labor and Delivery

Practice Questions

Management of Medical Disorders in Pregnancy

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free